Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

NCT07335601 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

MASH - Metabolic Dysfunction-Associated Steatohepatitis

Interventions

DRUG: Resmetirom
DRUG: Placebo

Sponsor

Madrigal Pharmaceuticals, Inc.